Literature DB >> 25207681

Differential expression of suppressor of cytokine signalling proteins in Behçet's disease.

M Hamedi1, L A Bergmeier, E Hagi-Pavli, S R Vartoukian, F Fortune.   

Abstract

Behçet's disease (BD) is a chronic, multisystemic, recurrent vasculitis disease of unknown aetiology. Proinflammatory cytokines are a key feature of the disease, but the triggers for their induction are not well understood and/or controversial. Suppressor of cytokine signalling (SOCS) proteins which negatively regulate the JAK-STAT signalling pathway of cytokine induction may be dysregulated in BD. The expression of SOCS1 and 3 mRNA and protein was studied in peripheral blood mononuclear cells (PBMCs) and neutrophils of patients with BD and compared with healthy controls (HCs) and patients with recurrent aphthous stomatitis (RAS) using RT-PCR, Western blot and immunohistochemistry. SOCS1 and 3 mRNA was also measured in buccal mucosal cells (BMC) of patients with BD and HCs. SOCS1 and 3 mRNA was significantly upregulated in PBMCs of patients with BD compared with HCs (P = 0.0149; P = 0.0007). In addition, there were subtle differences between expression in active and symptom-free BD (quiescent BD). SOCS1 and SOCS 3 were also significantly upregulated in BMC from oral ulcers of BD compared with HCs (both at P = 0.0001). A differential expression of both SOCS1 and 3 was observed between PBMCs and neutrophils in patients with BD. Immunohistochemical analysis revealed differential expression of SOCS proteins in the buccal mucosa with an increased expression at the ulcer surface of ulcers than in the non-ulcerated tissue. These observations suggest a dysregulation of the expression of these important regulators not only between patients with BD and healthy controls but also between mucosal and systemic tissues, which may reflect the nature of the aetiopathology of the disease.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25207681     DOI: 10.1111/sji.12211

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  6 in total

Review 1.  Knitting the Threads of Silk through Time: Behçet's Disease-Past, Present, and Future.

Authors:  Fahd Adeeb; Austin G Stack; Alexander D Fraser
Journal:  Int J Rheumatol       Date:  2017-09-10

2.  Gene Expression Profiling in Behcet's Disease Indicates an Autoimmune Component in the Pathogenesis of the Disease and Opens New Avenues for Targeted Therapy.

Authors:  Antonio Puccetti; Piera Filomena Fiore; Andrea Pelosi; Elisa Tinazzi; Giuseppe Patuzzo; Giuseppe Argentino; Francesca Moretta; Claudio Lunardi; Marzia Dolcino
Journal:  J Immunol Res       Date:  2018-04-24       Impact factor: 4.818

3.  The Expression of SOCS and NF-ϰB p65 in Hypopharyngeal Carcinoma.

Authors:  Shu Feng; Junfu Wang; Xiaoqun Xu; Xuemei Chen; Junwen Luan; Qinghong Su; Meng Luan; Huali Wang; Changsheng Zhao
Journal:  Iran J Public Health       Date:  2018-12       Impact factor: 1.429

Review 4.  Contribution of Janus-Kinase/Signal Transduction Activator of Transcription Pathway in the Pathogenesis of Vasculitis: A Possible Treatment Target in the Upcoming Future.

Authors:  Roberto Bursi; Giacomo Cafaro; Carlo Perricone; Ilenia Riccucci; Santina Calvacchi; Roberto Gerli; Elena Bartoloni
Journal:  Front Pharmacol       Date:  2021-03-29       Impact factor: 5.810

5.  Saliva and Serum Cytokine Profiles During Oral Ulceration in Behçet's Disease.

Authors:  Tanya Novak; Mojgan Hamedi; Lesley Ann Bergmeier; Farida Fortune; Eleni Hagi-Pavli
Journal:  Front Immunol       Date:  2021-12-22       Impact factor: 7.561

Review 6.  Gamma Delta (γδ) T Cells and Their Involvement in Behçet's Disease.

Authors:  Md Samiul Hasan; Lesley Ann Bergmeier; Harry Petrushkin; Farida Fortune
Journal:  J Immunol Res       Date:  2015-10-11       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.